SUMMARY. We have investigated the effects of phenytoin on the electrical and mechanical activity of isolated calf and dog cardiac Purkinje fibers. Phenytoin (5-100 HM) lowers and shortens the plateau phase of the Purkinje fiber action potential and reduces twitch tension. We studied the ionic basis of these effects by combining a conventional rwo-microelectrode voltage clamp procedure with pharmacological techniques that allow separation of time-dependent plateau membrane currents. We find that phenytoin reduces voltage-dependent calcium current in the Purkinje fiber. In addition, this drug slightly reduces two time-dependent outward currents. These effects of phenytoin on membrane current account, at least in part, for its influence on the action potential and twitch tension. (Circ Res 53: 16-23, 1983) 
PHENYTOIN, also known as diphenylhydantoin (DPH), has been used as a cardiac antiarrhythmic agent since 1958 (Leonard) and as an anticonvulsant since 1938 (Merritt and Putman) . However, despite its long history as a clinically effective drug, until recently, little has been known about how it affects the ionic currents that underlie electrical activity in excitable cells.
Recently, studies on squid giant axon and frog node of Ranvier have demonstrated that DPH reduces sodium current (I No ) (Lipicky et al., 1972) , and have begun to yield a description of how this reduction depends on pH and electrical activity (Schwarz and Vogel, 1977; Morello and Begenisich, 1979) . Experiments with action potentials recorded in cardiac preparations have suggested that DPH reduces sodium current in the heart as well (see Bigger et al., 1968; Jensen and Katzung, 1970; Rosen et al., 1976) , and, as in nerve, its interaction with the sodium channel may have a complex dependence on use and voltage (Ehring and Hondeghem, 1978) .
In the heart a second inward current, carried largely by calcium ions and referred to as slow inward current (1^), participates in many aspects of normal and pathological cardiac function (see Kass and Scheuer, 1982, for reveiw) . Results from previous studies in cardiac cells have suggested that DPH might also affect I n (Rosen et al., 1976; Bayer et al., 1977) . However, this speculation is based on the effects of this drug on normal and calciumdependent action potentials and twitch tension (Bayer et al., 1977) , and interpretation of these results is difficult because of the complex interaction of ionic currents that underlie the cardiac action potential.
In this paper, we report the results of experiments designed to test for effects of DPH on 1^ and other currents responsible for the Purkinje fiber action potential plateau. This study combines the voltage clamp technique with a recently introduced pharmacological procedure that allows separation of Lj from the two time-dependent outward plateau currents, I,o and I x . We find that DPH reduces I., in the Purkinje fiber. In addition, the drug inhibits the delayed rectifier, I x , and the transient outward current, I to .
Methods
The majority of these experiments were carried out in Purkinje fiber cell bundles dissected from either ventricle of calf hearts. These hearts were obtained at a local slaughterhouse, where they were immediately placed in ice-cold, oxygenated Tyrode's solution, and transported to the laboratory. The total elapsed travel time from the slaughterhouse to the laboratory was usually 15 minutes. Data in all figures were obtained from calf hearts.
For comparison, a small number (five) of experiments were carried out in Purkinje fibers obtained from dog hearts. Healthy, mongrel dogs were anesthetized with barbital and killed by injection of saturated KC1. Each animal was also shared with two other laboratories for other experimental purposes. These hearts were carefully rinsed and maintained in drug-free, ice-cold, oxygenated Tyrode's solution until further dissection was carried out.
Small Purkinje fiber cell bundles (1-2 mm long; 100-200 FIM diameter) were dissected from either the dog or calf hearts within 1 hour of sacrifice. Preparations were allowed to recover for at least 1 hour in 37°C oxygenated Tyrode's solution before use.
Membrane cun-ent was measured using a previously described two-microelectrode voltage clamp (Siegelbaum and Tsien, 1980) with electrode spacings appropriate for measurement of I* (Kass et al., 1979) . Microelectrodes were pulled from omega-dot glass (1.2 mm. o.d. x 0.9 mm i.d., Glass Co. of America) and bevelled with a modified spin bar beveller (Corson et al., 1979) . In some experiments, tension was measured with a force transducer, as described in an earlier study (Kass et al., 1978) .
Data Collection and Storage
All signals were recorded on a Brush 2400 chart recorder. In some experiments, data were recorded on an HP 3960 FM tape recorder (Hewlett-Packard) for later analysis on a PDP-1103 computer (Digital Equipment Corp.) . In later experiments, data were recorded directly using a PDP 1123 computer.
Solutions
The standard modified Tyrode solution contained 150 RRI M NaCl, 4 mM KC1 buffer, 5.4 mw CaCl 2 , 0.5 HIM MgCl 2 , 5 mM glucose, and 10 mw Tris-HCl buffer, pH 7.4. CaCl 2 concentration was reduced in some experiments, with no other ionic compensation. All solutions were gassed with 100% O 2 . Temperature was regulated with a thermoelectric device (Cambion) over a temperature range of 35-37°C with temperature held constant within ±0.5°C during a given experiment.
Drugs Used
DPH (5,5-diphenyl-imidazoline-2,4-dione) sodium salt (Sigma Chemical Corp) was dissolved in a 10 DIM stock solution made basic by addition of small quantities of concentrated KOH solution. Experimental solutions were prepared by dilution with appropriate amounts of normal Tyrode's solution. In aqueous solution at pH 7.4, DPH is only sparingly soluble and we could not be sure of concentrations >150 FIM. Thus, the concentration range that could be studied at normal pH was limited, and prevented the measurement of complete concentration-response relationships. D600 was generously supplied by Knoll Pharmaceuticals. This compound was prepared as a concentrated 10 mM aqueous solution. Terrodotoxin (TTX) (Calbiochem) was prepared in a 2.5 mM aqueous solution. Appropriate amounts of these concentrated stocks were diluted with Tyrode's solution for experiments. Current electrodes filled with 1.5 M tetrabutyl ammonium bromide (TBA) (Eastman Organic Chemicals) solution were used to inject this organic blocking compound, as previously described .
Voltage-Clamp Protocols
Holding potentials were chosen to inactivate the sodium current, IN, (Colatsky, 1980) , but not L (Reuter, 1979) , I lo (Fozzard and Hiraoka, 1973) ; TTX was used to block IN, in some experiments, eliminating interference from druginduced changes in a maintained component of IN, (Coraboeuf et al., 1979; Artwell et al., 1979; Colatsky and Gadsby, 1980) . We used the approach of Noble and Tsien (1969) to study l % [as described in the study by Kass (1982) ].
In experiments designed to measure U,, fibers were pretreated by iontophoretically injecting TBA using the electrodes described above. Outward current was passed under current or voltage clamp until signs of I to and l x were abolished. Experiments were carried out either using the TBA-filled electrode for current passing or by replacing it with one filled with 1.5 M K + -titrate. 
Statistics

Results
DPH causes marked changes in the electrical and mechanical activity of isolated cardiac Purkinje fibers. Figure 1 shows that a low DPH concentration (10 HM) lowers and shortens the plateau phase of driven action potentials and diminishes associated twitch tension. It also shows that both of these electrical and mechanical effects are reversible.
As a means for comparison with previous investigations, we measured DPH-induced changes in action potential duration measured at -40 mV (APD-40) over a DPH concentration range of 5-100 HM. The results, summarized in Table 1 , show a concentration-dependent reduction in ADP_ 40 similar to the effects of the drug previously reported in the canine Purkinje fiber (Rosen et al., 1976) . We then carried out voltage clamp experiments to identify the membrane currents responsible for these changes. Figure 2 shows the effects of DPH on Purkinje fiber membrane currents, using a voltage protocol that emphasizes changes in currents underlying the action potential plateau (see Methods). TTX was present during this experiment to minimize any effects due to background I Na (Attwell et al., 1979) . The insets are chart recorder records of membrane currents evoked by 500-msec voltage pulses to -10 mV in the absence and presence of DPH. The complex waveform of the current recorded using this protocol reflects the overlap of the three time-dependent plateau currents: I^, I to/ and l x . Because of the slow time base, and the frequency response of the chart recorder, I lo , although rather small in this preparation, appears as a "shoulder" of outward current that follows the capacity transient at the beginning of the depolarizing step. This subsides to reveal inward current due to I si . During the pulse, membrane current becomes less inward as Id inactivates, and the delayed rectifier, l x , is activated. As the current records reflect contributions from several conductances, it is difficult to assign DPH effects to any individual one. However, it is clear that for membrane current during the pulse to become more outward in the presence of DPH, I,d must be reduced or an outward current such as I to or I x must be increased.
Net Plateau Currents are More Outward in DPH
The effect of DPH on membrane currents has a potential dependence which is illustrated in the current-voltage relation of Figure 2 . At potentials negative to -30 mV, little difference is seen between control currents and those recorded in the presence of 10 HM DPH. However, at more positive potentials, currents in the presence of the drug are less inward than the control. Since calcium current in the Purkinje fiber is activated at potentials positive to -40 mV, the effect of DPH on this portion of the currentvoltage curve suggests that it might reduce 1*1. DPH consistently caused net membrane current to become more outward when test voltage steps were applied to voltages more positive than -30 mV. Table 2 summarizes the results of all of these experiments by comparing DPH-induced changes in peak inward current (A I) measured at test potentials near 0 mV in 15 different preparations. In each case, AI corresponds to a decrease in net inward current. Recovery from this effect was somewhat variable, and in some cases (such as the example shown in Fig. 2) , recovery of inward current was more complete than recovery of the outward transient.
DPH Reduces I,,
The first step in testing for possible effects of DPH on Ig, is to measure its effects on membrane current when the overlapping outward currents, I to and I x , have been minimized by injection of TBA (see Methods). DPH-induced changes in membrane currents in a fiber that had been loaded with TBA are shown in Figure 3 .
The insets are current records obtained in response to voltage clamp pulses from -40 mV to -20, -10, and 0 mV in the absence and presence of 50 /tM DPH. The control current records are representative of currents in other TBA-injected fibers with little sign of I to and I x . In response to depolarizing voltage clamp pulses, the inward calcium current peaks rapidly and then inactivates more slowly. In the presence of DPH, this inward peak is reduced at each potential shown. Peak inward currents from these and other voltage pulses were measured and plotted as the currentvoltage curves in Figure 3 . Inward current is reduced only at potentials positive to -30 mV. This voltage dependence is similar to that obtained from non-TBA-treated fibers (compare with Fig. 2) .
Thus, the effect of DPH on membrane current persists when outward currents have first been blocked by TBA, and these effects are observed in the absence and presence of TTX (compare Figs. 2  and 3) . We carried out a total of 34 experiments in fibers that had been injected with TBA. To compare the results from these experiments, we again tabu- lated DPH-induced changes in peak inward current (AI) at voltages measured near 0 mV. As in the experiments in which TBA had not been injected to block outward currents (Table 2) , AI was measured as a decrease of inward current in each case. In these experiments (after TBA injection), there was no significant difference between the changes in peak current induced by 20 and 50 /IM DPH, so these results were combined. After injecting TBA, we find a mean DPH-induced decrease in peak inward current, AI, of 18 ± 2.3 nA (n = 34, p < 0.001).
To confirm that DPH reduces calcium current, we applied three additional experimental criteria that should be met by a calcium current inhibitor. First, we measured the sensitivity of the current that is blocked by DPH to variation in extracellular calcium. Second, we tested for an effect of DPH on plateau current after calcium channels have been completely blocked by another calcium current blocker. Finally, we measured the effect of DPH on contractile activity under voltage clamp conditions.
The results of the first of these tests are shown in Figure 4 . In this experiment, the fiber was first injected with TBA to block outward current, and then records were obtained in the absence and presence of DPH in both 5.4 mM and 2.7 ITIM Ca ++ . DPH-sensitive current (a-b) was obtained by subtracting the current recorded in DPH from the drugfree current record in each calcium concentration. In this way, the current blocked by DPH in each calcium concentration can be measured directly.
The DPH-sensitive current is dependent on extracellular calcium. The drug-sensitive current at -2 mV (inset, Fig. 4 sitive current by a factor of 0.22. In the second preparation, a reduction in [Ca^Jo from 5.4 to 1.8 mM reduced the DPH-sensitive current by a factor of 0.35. As in the previous experiment, there is little effect of the drug at potentials negative to -30 mV under these conditions. The results of the second test for the identity of the DPH-sensitive current are shown in Figure 5 . Once again, TBA was first injected to block outward current. In this experiment, D600 (10 ^M) was first applied while test voltage pulses were applied from a -40 mV holding potential to a test potential of -5 mV at a rate of 0.2 Hz. Under these conditions, D600 completely blocks 1^ (Kass and Wiegers, 1982) , and this is evident in the current trace (labeled D600) obtained after a 28-minute exposure to this drug. After recording this current trace, 50 fiM DPH was added to the perfusate while test pulses were continually applied and the D600 concentration was maintained. After 12 minutes in this solution, membrane current shows no additional change (D600 + DPH trace)., Thus, when calcium current is first blocked by D600, DPH has little effect on the plateau current that remains. We confirmed this finding in two additional preparations.
The results of the final test for DPH are shown in Figure 6 , which shows that DPH reduces twitch tension when membrane potential is controlled. In this experiment, 5 00-msec depolarizing voltage pulses were applied repetitively from a -60 mV holding potential once every 2 seconds. DPH (100 MM) was added to the perfusate while these test pulses were applied, and the effects of the drug reached a steady state 15 minutes after this change in solution. The figure shows examples of twitch tension records obtained before the drug was applied and after steady state reduction in twitch tension had occurred. At each potential, the twitch is dramatically reduced in DPH. Reductions in tension were observed in each of four similar voltage clamp experiments.
DPH Reduces Outward Plateau Currents
The calcium current experiments were carried out in preparations that had been injected with TBA to minimize outward currents. Figure 7 shows data recorded from a fiber that had not been treated with TBA. Since outward currents are not blocked in this case, we could measure I x tails (see Methods) following long (1.5-second) depolarizing voltage steps in the absence and presence of DPH. We find that the drug reduces the magnitude of these tails. The figure shows I x tails in the absence and presence of DPH. It also shows isochronal I x activation curves constructed from similar tails following pulses to a series of test voltages. The results show that DPH reduces I x over this entire range of voltages, and, in this experiment, the effect was completely reversible. These results are typical of experiments where DPH concentrations >100 MM were used. At these high concentrations, I x was reduced in each of three calf and three dog fibers. At lower concentrations (30 ^M), the results were less consistent. Reductions were observed in only one of five experiments in calf Purkinje fibers and in one of three experiments in dog fibers. Thus, whereas DPH had clear effects on I x/ these effects occurred at higher concentrations than did its effects on I n .
DPH also reduces the transient outward current (I to ). The presence of this current is evidenced by an outward hump in current records obtained during depolarizing voltage clamp steps in preparations that have not been injected with TBA (Fig. 8a) . The magnitude of this current varies from fiber to fiber (compare Figs. 2 and 8) . DPH (50 MM) reduces this outward peak, in addition to its effect on the early inward peak associated with 1^ (Fig. 8b) . This reduction in I to is more readily visualized when the net drug-sensitive current is obtained by subtraction (a -b). This record, showing the current affected by DPH, contains a small but clear component of I to . We examined the effect of 50 MM DPH to I lo in three other fibers and found small reductions of this type in each of them. As I to is at least partially activated by calcium ions in calf Purkinje fibers (Siegelbaum and Tsien, 1980) , these effects are not necessarily due to a direct effect of the drug on I, o , but may be secondary to the reduction of calcium influx via IsThus, DPH, like several previously studied calcium current blockers, reduces I to and I x , in addition to its effect on calcium current (Kass and Tsien, 1975; Siegelbaum et al., 1977) , but in each case the effect is rather small.
Discussion
The primary goal of this study has been to characterize the effects of DPH on time-dependent plateau currents in cardiac Purkinje fibers. As predicted from its effects on the action potential plateau, net plateau currents are more outward in the presence of DPH. We find that a block of inward calcium current is largely responsible for this change in membrane current.
This conclusion is based on several observations. First, we find that the reduction of net inward plateau current by DPH persists when the outward currents I to and I x are blocked by intracellular TBA. Second, the inward current blocked by DPH is not influenced by the absence or presence of high concentrations of TTX. Since this effect persists in the presence of high TTX concentrations (see Fig. 2) , it is not a secondary response to DPH block of sodium channels. (Perry et al., 1978) . Several additional properties identify the DPH-sensitive inward current as voltage-dependent calcium current. The DPH-sensitive current displays a time course and voltage dependence similar to that of the calcium current. The DPH-sensitive current is appropriately sensitive to extracellular calcium concentration and the effect of DPH is occluded by pretreatment with D600. Finally, DPH reduces twitch tension over a voltage range that is consistent with a reduction in Isi- The reduction by DPH of calcium uptake induced by depolarization has been reported in synaptosome preparations (Sohn and Ferrendelli, 1973; Ferrendelli and Daniels-McQueen, 1982) . The present findings extend these observations to cardiac preparations and conclusively demonstrate an effect of DPH on the voltage-sensitive calcium channel.
The current blocked by DPH in TBA-treated fibers has several other properties normally associated with calcium channels. Block by D600 and other calcium channel blockers reveals a component of calcium-sensitive maintained current at the end of pulses in addition to their effects on peak currents (Kass et al., 1976) . DPH, too, blocks calcium-sensitive maintained current.
DPH was also found to reduce outward currents, although to a somewhat lesser extent than it reduces k. Inhibition of outward currents by DPH has been observed in Aplysia neurons (Lewis, 1981) , and studies in crayfish giant axon suggest that it reduces potassium conductance in that preparation as well (Nosek, 1981) . Therefore, this effect is not peculiar to cardiac preparations but appears to be a more general characteristic of DPH.
As a group, calcium channel blockers in the heart are nonspecific and have additional effects on other membrane currents (Kass and Tsien, 1975) . The transient outward current, I to/ is reduced by other calcium current-blocking compounds (Siegelbaum et al., 1977; Siegelbaum and Tsien, 1980) , and this is also true of DPH. This is not surprising, as I lo is at least partially activated by calcium ions (Siegelbaum and Tsien, 1980) . DPH reduces I*, an outward current that contributes to the termination of the action potential plateau. Other calcium channel blockers also reduce this current in calf Purkinje fibers (Kass and Tsien, 1975) but at least one, nisoldipine, does not (Kass, 1982) . These reductions in outward current counteract effects of DPH on inward currents and modulate its effect on the action potential.
DPH also has major effects on I N , which were not dealt with in this study. DPH blocks sodium channels in lobster nerve (Pincus, 1972) , and squid giant axon (Lipicky et al., 1972; Morello and Begenisich, 1979) and reduces V^ of the Na-dependent action potential upstroke in cardiac preparations (for review, see Wit et al., 1975) . Like sodium channel blockade by local anesthetics, block by this compound displays use and voltage-dependent characteristics (Ehring and Hondeghem, 1978; Schwarz and Vogel, 1977; Morello, 1982) . This complicated dependence on time and voltage makes it difficult to assess the relative importance of sodium channel blockade, in comparison with its effects on other currents, when examining electrical activity as complex as the cardiac action potential.
The fact that DPH reduces I S1 and makes net currents more outward provides explanations for some of its previously reported effects. Several groups have found that DPH lowers and shortens the plateau phase of the action potential plateau (Bigger et al., 1968) and reduces dV/dT^x of slow response action potentials (Rosen et al., 1976; Bayer et al., 1978) . These effects are consistent with a reduction of I^. The present findings also provide a possible explanation for reports that DPH favors repolarization of depolarized Purkinje fibers (Arnsdorf and Mehlman, 1978) . The outward currents associated with repolarization are not increased by DPH. However, a reduction in the maintained component of calcium current is consistent with these results reported for action potentials.
DPH has been reported to be useful as an antiarrhythmic compound when plasma levels of the drug are 10-18 ^g/ml, and occasionally when levels are 3-4 Mg/ml (Bigger et al., 1966 (Bigger et al., , 1968 . This corresponds to a DPH concentration range of 11-66 /ZM which overlaps drug levels that produce calcium current inhibition in our study. Thus, it appears likely that some of the clinical antiarrhythmic actions of this compound are due to its interactions with calcium channel current.
Circulation Research/Vol. 53, No. 1, July 1983 The present study examines actions of DPH on currents underlying the action potential plateau, using techniques that allow separating individual components of net membrane current. The most prominent effect of DPH is the marked reduction of the calcium current that is responsible for maintaining the action potential plateau. Tension also is reduced, an effect that may be associated with the reduction in L-Finally, smaller reductions in the outward currents, I x and I lo , are associated with exposure to DPH. The complexity of these effects helps explain the diverse results observed in studies of DPH on cardiac action potentials.
